Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
174.46
-6.86 (-3.78%)
At close: Mar 6, 2026, 4:00 PM EST
175.00
+0.54 (0.31%)
After-hours: Mar 6, 2026, 7:33 PM EST
CRL Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for CRL stock have an average target of 197.58, with a low estimate of 170 and a high estimate of 265. The average target predicts an increase of 13.25% from the current stock price of 174.46.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRL stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 9 | 7 | 6 | 6 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 14 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $170 → $175 | Hold | Maintains | $170 → $175 | +0.31% | Feb 25, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $251 → $235 | Strong Buy | Maintains | $251 → $235 | +34.70% | Feb 20, 2026 |
| Mizuho | Mizuho | Hold Maintains $215 → $175 | Hold | Maintains | $215 → $175 | +0.31% | Feb 20, 2026 |
| Barclays | Barclays | Buy Maintains $215 → $200 | Buy | Maintains | $215 → $200 | +14.64% | Feb 19, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $260 → $200 | Buy | Maintains | $260 → $200 | +14.64% | Feb 19, 2026 |
Financial Forecast
Revenue This Year
4.10B
from 4.02B
Increased by 2.11%
Revenue Next Year
4.22B
from 4.10B
Increased by 2.95%
EPS This Year
11.15
from -2.91
EPS Next Year
12.16
from 11.15
Increased by 9.01%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.3B | 4.6B | |||
| Avg | 4.1B | 4.2B | |||
| Low | 4.0B | 3.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.1% | 11.1% | |||
| Avg | 2.1% | 3.0% | |||
| Low | -1.6% | -6.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.30 | 13.74 | |||
| Avg | 11.15 | 12.16 | |||
| Low | 10.65 | 10.96 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 23.2% | |||
| Avg | - | 9.0% | |||
| Low | - | -1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.